INmune Bio, Inc

(NASDAQ:INMB)

Latest On INmune Bio, Inc (INMB):

Date/Time Type Description Signal Details
2023-05-08 11:51 ESTNewsINmune Bio gets FDA IND approval for prostate cancer immunotherapyN/A
2023-05-04 00:56 ESTNewsINmune Bio GAAP EPS of -$0.36N/A
2023-05-04 00:55 ESTNewsINmune Bio, Inc. (INMB) Q1 2023 Earnings Call TranscriptN/A
2023-04-24 07:21 ESTNewsINmune Bio: Alzheimer's Disease Treatment Lottery TicketN/A
2023-04-03 22:50 ESTNewsINmune rises 7% after company files application to begin trial of cancer treatmentN/A
2023-03-03 08:05 ESTNewsINmune Bio, Inc. (INMB) Q4 2022 Earnings Call TranscriptN/A
2023-03-02 17:57 ESTNewsINmune Bio GAAP EPS of -$1.52 beats by $0.14, revenue of $0.37M beats by $0.17MN/A
2023-03-02 03:13 ESTNewsINmune Bio FY 2022 Earnings PreviewN/A
2023-02-08 22:42 ESTNewsINmune Bio to fund Alzheimer’s trial with over $6M R&D rebatesN/A
2023-01-05 10:19 ESTNewsINmune Bio: INKmune For Solid Tumors And Other Potential CatalystsN/A
2022-11-22 21:57 ESTNewsINmune Bio, High Risk, Higher RewardN/A
2022-11-22 03:40 ESTNewsINmune Bio, High Risk, Higher Reward.N/A
2022-11-14 10:27 ESTNewsINmune receives green signal from Canada to begin trial of XPro1595 in mild Alzheimer’s DiseaseN/A
2022-11-04 04:11 ESTNewsINmune Bio, Inc. (INMB) Q3 2022 Earnings Call TranscriptN/A
2022-11-02 18:55 ESTNewsINmune Bio GAAP EPS of -$0.43N/A
2022-11-02 03:01 ESTNewsINmune Bio Q3 2022 Earnings PreviewN/A
2022-08-03 22:07 ESTNewsINmune Bio GAAP EPS of -$0.38N/A
2022-08-03 22:07 ESTNewsINmune Bio, Inc's (INMB) CEO RJ Tesi on Q2 2022 Results - Earnings Call TranscriptN/A
2022-08-03 07:18 ESTNewsINmune Bio Q2 2022 Earnings PreviewN/A
2022-06-22 21:25 ESTNewsINmune Bio gets US patent covering use of XPro for neurological disordersN/A
2022-05-25 18:53 ESTNewsINmune Bio: Possibly The Once In A Lifetime DipN/A
2022-05-24 20:43 ESTNewsINmune Bio down 22% on Alzheimer's candidate mid-stage trial holdN/A
2022-05-23 22:31 ESTNewsINmune says FDA put on hold application to start phase 2 trial of Alzheimer's treatmentN/A
2022-05-08 17:53 ESTNewsINmune Bio's (INMB) CEO RJ Tesi on Q1 2022 Results - Earnings Call TranscriptN/A
2022-05-06 04:08 ESTNewsINmune Bio GAAP EPS of -$0.39, revenue of $0.2MN/A
2022-05-05 04:57 ESTNewsINmune Bio Q1 2022 Earnings PreviewN/A
2022-04-13 18:54 ESTNewsINmune starts dosing in phase 2 XPro1595 trial to treat neuroinflammation due to Alzheimer’sN/A
2022-04-05 10:20 ESTNewsINmune Bio: Speculative Biotech With 2 Solid Potential Approaches To Treating AD And Solid TumorsN/A
2022-03-04 06:45 ESTNewsINmune Bio GAAP EPS of -$1.88 misses by $1.30, revenue of $0.18MN/A
2022-03-04 06:44 ESTNewsINmune Bio, Inc. (INMB) CEO Raymond J. Tesi on Q4 2021 Results - Earnings Call TranscriptN/A
2022-01-17 15:18 ESTNewsINmune Bio, The Biotech In My Stable For After Cassava SciencesN/A
2021-12-03 15:54 ESTNewsWarning: INMB is at high risk of performing badlyN/A
2021-11-04 11:05 ESTNewsINmune Bio, Inc. (INMB) CEO R. J. Tesi on Q3 2021 Results - Earnings Call TranscriptN/A
2021-11-02 17:58 ESTNewsINmune Bio Q3 2021 Earnings PreviewN/A
2021-10-13 23:24 ESTNewsINmune Bio A No-Brainer InvestmentN/A
2021-09-09 06:27 ESTNewsINmune slides 20% following 192.5K share offering from XencorN/A
2021-09-02 21:16 ESTNewsINmune Bio jumps 11% after XPro data in Alzheimer’s diseaseN/A
2021-08-18 11:30 ESTNewsINmune Bio: High-Risk High-Reward Alzheimer's PlayN/A
2021-08-12 19:07 ESTNewsOur Bullish Take On INmune Bio's Drug PipelineN/A
2021-08-08 14:03 ESTNewsINmune Bio, Inc. (INMB) CEO David Moss on Q2 2021 Results - Earnings Call TranscriptN/A
2021-08-05 06:48 ESTNewsINmune Bio EPS misses by $0.10N/A
2021-07-26 17:55 ESTNewsINMune releases design for phase 2 trial of Alzheimer's candidate XPro1595N/A
2021-07-23 01:31 ESTNewsINmune Bio acquires LUMICKS' z-Movi Cell Avidity AnalyzerN/A
2021-07-21 12:41 ESTNewsINmune enters $15M credit facility to fund purchase of Xencor optionN/A
2021-07-21 12:27 ESTNewsCassava, Annovis, and INmune PTs raised at Maxim on aducanumab approvalN/A
2021-07-21 12:26 ESTNewsINmune Bio surges ahead of key data readoutN/A
2021-07-21 12:25 ESTNewsINmune treats first patient in early-stage INKmune MDS studyN/A
2021-07-21 12:24 ESTNewsINmune Bio: Underfollowed AD Player With Very Bullish August MomentumN/A
2021-07-21 12:24 ESTNewsINmune Bio under pressure on launch of $40M direct offeringN/A
2021-05-06 14:04 ESTNewsINmune Bio, Inc. (INMB) CEO RJ Tesi on Q1 2021 Results - Earnings Call TranscriptN/A

About INmune Bio, Inc (INMB):

INmune Bio, Inc., a clinical-stage immunotherapy company, focuses on reprogramming the patient's innate immune system to treat cancer Alzheimer's disease, and non-alcoholic steatohepatitis. The company intends to develop and commercialize product candidates to treat hematologic malignancies, solid tumors, and chronic inflammation. Its development programs include INKmune, which focuses on treating women with relapse refractory ovarian carcinoma and patients with high-risk myelodysplastic syndrome; INB03 that treats patients with advanced cancers with elevated biomarkers of inflammation in their blood; XPro1595 for the treatment of Alzheimer's disease; LivNate to treat patients with non-alcoholic steatohepatitis; and Quellor for cytokine release syndrome and complications of COVID-19. The company has license agreements with Xencor, Inc.; Immune Ventures, LLC; University of Pittsburg; and University College London. INmune Bio, Inc. was incorporated in 2015 and is headquartered in La Jolla, California.

INMB Quotes by TradingView

See Advanced Chart

General

  • Name INmune Bio, Inc
  • Symbol INMB
  • Type Common Stock
  • Exchange NASDAQ
  • Currency USD
  • Country USA
  • SectorHealthcare
  • IndustryBiotechnology
  • Full Time Employees 5
  • Fiscal Year EndDecember
  • IPO Date2019-02-04
  • Gic SectorHealth Care
  • Gic GroupPharmaceuticals, Biotechnology & Life Sciences
  • Gic IndustryBiotechnology
  • Gic SubIndustryBiotechnology
  • Web URLhttp://www.inmunebio.com
View More

Valuation

  • Price/Sales (Trailing 12 Mt.) 15957.57
  • Price/Book (Most Recent Quarter) 5.6
  • Enterprise Value Revenue 17878.76
View More

Financials

  • Most Recent Quarter 2020-12-31
  • Current Year EPS Estimate -$1.05
  • Next Year EPS Estimate -$1.87
  • Next Quarter EPS Estimate -$0.38
  • Operating Margin -112016%
  • Return on Assets -23%
  • Return on Equity -39%
  • Revenue 10916
  • Earnings Per Share -$0.62
  • Revenue Per Share $0
  • Gross Profit 10916
  • Quarterly Earnings Growth 0%
View More

Highlights

  • Market Capitalization 222.05 million
  • PE Ratio -6.44
  • Analyst Target Price $29.67
  • Book Value Per Share $2.88
View More

Share Statistics

  • Shares Outstanding 14.93 million
  • Shares Float 8.87 million
  • % Held by Insiders 4507%
  • % Held by Institutions 12.61%
  • Shares Short 364561
  • Shares Short Prior Month 447423
  • Short Ratio 1.11
  • Short % of Float 4%
  • Short % of Shares Outstanding 3%
View More

Technicals

  • Beta 2.96
  • 52 Week High $29.99
  • 52 Week Low $2.22
  • 50 Day Moving Average 17.86
  • 200 Day Moving Average 13.14
View More

Dividends

  • Dividend Date N/A
  • ExDividend Date N/A
  • Dividend Yield 0%
View More

INmune Bio, Inc (INMB) Dividend Calendar:

Ex-Dividend Date Payment Date Record Date Declared Date Amount

INmune Bio, Inc (INMB) Earnings History:

Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.


Quarter Date Report Date Actual Revenue Reported EPS EPS Estimate Deviation from Estimate
2020-12-312021-03-04$10916-$0.26-$0.3115.45%
2020-09-302020-11-05$N/A-$0.36-$0.17-108.7%
2020-06-302020-08-05$N/A-$0.20-$0.2313.04%
2020-03-312020-05-14$N/A-$0.19-$0.219.52%
2019-12-312020-03-11$N/A-$0.22-$0.247.37%
2019-09-302019-11-08$N/A-$0.28-$0.19-44.85%
2019-06-302019-08-09$N/A-$0.04-$0.2080%
2019-03-312019-05-15$N/A-$0.20-$0.19-5.26%
2018-12-312019-03-29$N/A-$0.21-$0.19-10.53%

INmune Bio, Inc (INMB) Company Financial Statements:

Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.

Income Statement:
Date
Research Development
Income Before Tax
Selling General Administrative
Gross Profit
Ebit
Operating Income
Income Tax Expense
Total Revenue
Cost of Revenue
Total Other Income Expense Net
Net Income From Continuing Operations
Net Income Applicable to Common Shares
Cash Flow:
Date
Investments
Change to Liabilities
Total Cash Flow from Investing Activities
Net Borrowings
Total Cash Flow from Financial Activities
Change to Operating Activities
Change in Cash
Total Cash from Operating Activities
Depreciation
Other Cash Flow from Investing Activities
Change to Inventory
Change to Account Receivables
Other Cash Flow from Financing Activities
Change to Net Income
Capital Expenditures
Balance Sheet:
Date
Total Liabailities
Total Stockholder Equity
Other Current Liabilities
Total Assets
Common Stock
Other Current Assets
Retained Earnings
Other Liabilities
Other Assets
Cash
Total Current Liabilities
Other Stockholder Equity
Property, Plant & Equipment
Total Current Assets
Long Term Investments
Net Tangible Assets
Short Term Investments
Long Term Debt
Inventory
Accounts Payable

INmune Bio, Inc (INMB) Chart:

INmune Bio, Inc (INMB) News:

Below you will find a list of latest news for INmune Bio, Inc (INMB) from major news sources. You can filter the results to only show news from a specific source.

No recent news available

INmune Bio, Inc (INMB) Options:

A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.

Expiration Date Strike Last Price Type Volume Open Interest Implied Volatility In The Money Change Change Percent
2024-05-172.50CALL0 0344.53TRUE00
2024-05-1750CALL0 0289.14TRUE00
2024-05-177.50CALL0 0375.91TRUE00
2024-05-17100.84CALL8 44550.52TRUE0.190.29
2024-05-1712.50.35CALL59 10690.24FALSE0.050.17
2024-05-17150.46CALL0 10FALSE00
2024-05-1717.50.6CALL0 20FALSE00
2024-05-17200.1CALL0 140FALSE00
2024-05-1722.50CALL0 00FALSE00
2024-05-172.50PUT0 00FALSE00
2024-05-1750PUT0 00FALSE00
2024-05-177.50.06PUT6 24894.98FALSE-0.04-0.4
2024-05-17100.4PUT5 2167.07FALSE-0.25-0.38
2024-05-1712.50PUT0 0158.42TRUE00
2024-05-17150PUT0 0187.65TRUE00
2024-05-1717.50PUT0 0266.46TRUE00
2024-05-17200PUT0 0299.95TRUE00
2024-05-1722.50PUT0 0365.31TRUE00
2024-06-212.59.6CALL0 0765.48TRUE00
2024-06-2154.3CALL0 2378.43TRUE00
2024-06-217.53.6CALL20 227107.31TRUE3.60
2024-06-21101.5CALL0 33676.97TRUE00
2024-06-2112.50.65CALL2 11375.19FALSE0.10.18
2024-06-21150.18CALL0 53583.12FALSE00
2024-06-2117.50.26CALL0 1450FALSE00
2024-06-21200.38CALL0 50132.68FALSE00
2024-06-2122.50.25CALL0 60FALSE00
2024-06-21250.33CALL0 340FALSE00
2024-06-212.50.15PUT0 20FALSE00
2024-06-2150.6PUT0 20FALSE00
2024-06-217.50.45PUT0 21170.33FALSE00
2024-06-21101.25PUT0 2172.18FALSE00
2024-06-2112.51.8PUT0 3175.8TRUE00
2024-06-21153.1PUT0 4142.67TRUE00
2024-06-2117.50PUT0 0179.03TRUE00
2024-06-21208PUT0 0177.16TRUE00
2024-06-2122.50PUT0 0180TRUE00
2024-06-21250PUT0 0194.94TRUE00
2024-09-202.50CALL0 0204.58TRUE00
2024-09-2050CALL0 0114.51TRUE00
2024-09-207.53.34CALL0 158127.99TRUE00
2024-09-20102.6CALL10 29584.22TRUE2.60
2024-09-2012.51.05CALL0 43104.97FALSE00
2024-09-20151.01CALL0 39679.18FALSE00
2024-09-2017.50.51CALL0 2884.3FALSE00
2024-09-20200.43CALL0 22131.13FALSE00
2024-09-2022.50.05CALL0 18142.07FALSE00
2024-09-20250.25CALL0 45108.97FALSE00
2024-09-202.50PUT0 00FALSE00
2024-09-2050.29PUT0 10FALSE00
2024-09-207.50.92PUT0 580.96FALSE00
2024-09-20101.65PUT0 291.08FALSE00
2024-09-2012.52.65PUT0 168.72TRUE00
2024-09-20150PUT0 087.07TRUE00
2024-09-2017.50PUT0 087TRUE00
2024-09-20207.2PUT0 2095.41TRUE00
2024-09-2022.50PUT0 0138.61TRUE00
2024-09-20250PUT0 0113.63TRUE00
2024-12-202.50CALL0 0133.61TRUE00
2024-12-2056.69CALL40 0128.92TRUE6.690
2024-12-207.50CALL0 085.57TRUE00
2024-12-20103.47CALL3 1092.7TRUE3.470
2024-12-2012.52.75CALL0 1892.29FALSE00
2024-12-20152.09CALL3 14094.42FALSE-0.01-0
2024-12-2017.51.75CALL0 9295.48FALSE00
2024-12-202.50PUT0 00FALSE00
2024-12-2050PUT0 0104.7FALSE00
2024-12-207.50PUT0 0100.2FALSE00
2024-12-20100PUT0 084.9FALSE00
2024-12-2012.50PUT0 0103.17TRUE00
2024-12-20150PUT0 0100.14TRUE00
2024-12-2017.50PUT0 085.93TRUE00

Latest INMB Trades:

Date Shares Price
Jun 13, 2022 7:46 PM EST120$6.635
Jun 13, 2022 7:50 PM EST100$6.62
Jun 13, 2022 7:51 PM EST60$6.605
Jun 13, 2022 7:55 PM EST365$6.62
Jun 13, 2022 7:56 PM EST10$6.62

INmune Bio, Inc (INMB) SEC Filings:

An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.

Date Form Type Form Name Link
2020-06-158-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1711754/000121390020014985/0001213900-20-014985-index.htm
2019-06-27UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/1711754/000000000019010444/0000000000-19-010444-index.htm
2019-07-24UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/1711754/000000000019011485/0000000000-19-011485-index.htm
2020-03-31UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/1711754/000000000020002785/0000000000-20-002785-index.htm
2020-01-294Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1711754/000110465920008253/0001104659-20-008253-index.htm
2020-02-14SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1711754/000110465920021049/0001104659-20-021049-index.htm
2019-02-083Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1711754/000120919119008770/0001209191-19-008770-index.htm
2019-02-083Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1711754/000120919119008772/0001209191-19-008772-index.htm
2019-08-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1711754/000121390019015380/0001213900-19-015380-index.htm
2019-08-138-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1711754/000121390019015549/0001213900-19-015549-index.htm
2019-08-158-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1711754/000121390019016070/0001213900-19-016070-index.htm
2019-08-163Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1711754/000121390019016187/0001213900-19-016187-index.htm
2019-08-214Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1711754/000121390019016453/0001213900-19-016453-index.htm
2019-08-214Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1711754/000121390019016455/0001213900-19-016455-index.htm
2019-08-224Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1711754/000121390019016514/0001213900-19-016514-index.htm
2019-08-278-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1711754/000121390019016813/0001213900-19-016813-index.htm
2019-09-048-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1711754/000121390019017204/0001213900-19-017204-index.htm
2019-09-098-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1711754/000121390019017510/0001213900-19-017510-index.htm
2019-09-128-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1711754/000121390019017870/0001213900-19-017870-index.htm
2019-09-128-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1711754/000121390019017874/0001213900-19-017874-index.htm
2019-09-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1711754/000121390019017904/0001213900-19-017904-index.htm
2019-09-188-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1711754/000121390019018359/0001213900-19-018359-index.htm
2019-09-238-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1711754/000121390019018683/0001213900-19-018683-index.htm
2019-09-308-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1711754/000121390019019236/0001213900-19-019236-index.htm
2019-10-088-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1711754/000121390019019987/0001213900-19-019987-index.htm
2019-10-218-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1711754/000121390019020655/0001213900-19-020655-index.htm
2019-11-0810-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1711754/000121390019022556/0001213900-19-022556-index.htm
2019-11-128-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1711754/000121390019022948/0001213900-19-022948-index.htm
2019-11-208-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1711754/000121390019024216/0001213900-19-024216-index.htm
2019-11-274Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1711754/000121390019024949/0001213900-19-024949-index.htm
2019-11-274Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1711754/000121390019024951/0001213900-19-024951-index.htm
2019-11-274Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1711754/000121390019024954/0001213900-19-024954-index.htm
2019-11-274Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1711754/000121390019024956/0001213900-19-024956-index.htm
2019-11-274Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1711754/000121390019024961/0001213900-19-024961-index.htm
2019-11-274Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1711754/000121390019024968/0001213900-19-024968-index.htm
2019-11-274Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1711754/000121390019024971/0001213900-19-024971-index.htm
2019-11-298-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1711754/000121390019025038/0001213900-19-025038-index.htm
2019-12-038-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1711754/000121390019025204/0001213900-19-025204-index.htm
2019-12-178-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1711754/000121390019026351/0001213900-19-026351-index.htm
2020-01-028-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1711754/000121390020000044/0001213900-20-000044-index.htm
2020-01-093Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1711754/000121390020000646/0001213900-20-000646-index.htm
2020-01-138-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1711754/000121390020000847/0001213900-20-000847-index.htm
2020-01-278-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1711754/000121390020001935/0001213900-20-001935-index.htm
2020-02-108-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1711754/000121390020003050/0001213900-20-003050-index.htm
2020-02-14SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1711754/000121390020003972/0001213900-20-003972-index.htm
2020-02-14SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1711754/000121390020003973/0001213900-20-003973-index.htm
2020-02-14SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1711754/000121390020003974/0001213900-20-003974-index.htm
2020-03-048-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1711754/000121390020005391/0001213900-20-005391-index.htm
2020-03-098-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1711754/000121390020005786/0001213900-20-005786-index.htm
2020-03-1110-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1711754/000121390020005916/0001213900-20-005916-index.htm
2020-03-128-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1711754/000121390020006109/0001213900-20-006109-index.htm
2020-03-24S-3Registration statement under Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1711754/000121390020007264/0001213900-20-007264-index.htm
2020-03-31CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1711754/000121390020008226/0001213900-20-008226-index.htm
2020-04-098-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1711754/000121390020008917/0001213900-20-008917-index.htm
2020-04-14POS AMPost-Effective amendments for registration statementhttps://www.sec.gov/Archives/edgar/data/1711754/000121390020009194/0001213900-20-009194-index.htm
2020-04-178-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1711754/000121390020009372/0001213900-20-009372-index.htm
2020-04-17424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1711754/000121390020009374/0001213900-20-009374-index.htm
2020-04-218-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1711754/000121390020009642/0001213900-20-009642-index.htm
2020-04-218-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1711754/000121390020009707/0001213900-20-009707-index.htm
2020-04-228-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1711754/000121390020009822/0001213900-20-009822-index.htm
2020-04-238-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1711754/000121390020009925/0001213900-20-009925-index.htm
2020-04-24424B3Prospectus [Rule 424(b)(3)]https://www.sec.gov/Archives/edgar/data/1711754/000121390020010039/0001213900-20-010039-index.htm
2020-04-288-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1711754/000121390020010301/0001213900-20-010301-index.htm
2020-05-058-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1711754/000121390020010962/0001213900-20-010962-index.htm
2020-05-078-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1711754/000121390020011278/0001213900-20-011278-index.htm
2020-05-128-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1711754/000121390020011855/0001213900-20-011855-index.htm
2020-05-1410-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1711754/000121390020012056/0001213900-20-012056-index.htm
2020-05-158-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1711754/000121390020012422/0001213900-20-012422-index.htm
2020-05-188-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1711754/000121390020012725/0001213900-20-012725-index.htm
2020-05-208-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1711754/000121390020013101/0001213900-20-013101-index.htm
2020-06-158-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1711754/000121390020014985/0001213900-20-014985-index.htm
2020-07-108-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1711754/000121390020017207/0001213900-20-017207-index.htm
2020-07-138-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1711754/000121390020017343/0001213900-20-017343-index.htm
2020-07-15424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1711754/000121390020017565/0001213900-20-017565-index.htm
2020-07-168-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1711754/000121390020017615/0001213900-20-017615-index.htm
2020-07-16424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1711754/000121390020017634/0001213900-20-017634-index.htm
2020-07-208-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1711754/000121390020017924/0001213900-20-017924-index.htm
2020-07-218-K/ACurrent reporthttps://www.sec.gov/Archives/edgar/data/1711754/000121390020018013/0001213900-20-018013-index.htm
2020-07-288-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1711754/000121390020018871/0001213900-20-018871-index.htm
2020-07-308-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1711754/000121390020019177/0001213900-20-019177-index.htm
2020-08-038-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1711754/000121390020019888/0001213900-20-019888-index.htm
2020-08-0510-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1711754/000121390020020373/0001213900-20-020373-index.htm
2020-08-068-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1711754/000121390020020662/0001213900-20-020662-index.htm
2020-08-078-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1711754/000121390020020897/0001213900-20-020897-index.htm
2020-08-148-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1711754/000121390020022288/0001213900-20-022288-index.htm
2020-08-198-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1711754/000121390020022769/0001213900-20-022769-index.htm
2020-08-19424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1711754/000121390020022773/0001213900-20-022773-index.htm
2020-08-21DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/1711754/000121390020023303/0001213900-20-023303-index.htm
2020-09-038-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1711754/000121390020025123/0001213900-20-025123-index.htm
2020-09-048-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1711754/000121390020025397/0001213900-20-025397-index.htm
2020-09-158-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1711754/000121390020026558/0001213900-20-026558-index.htm
2020-09-178-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1711754/000121390020027055/0001213900-20-027055-index.htm
2020-09-248-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1711754/000121390020028229/0001213900-20-028229-index.htm
2020-09-298-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1711754/000121390020028780/0001213900-20-028780-index.htm
2020-10-018-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1711754/000121390020029548/0001213900-20-029548-index.htm
2020-10-068-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1711754/000121390020030205/0001213900-20-030205-index.htm
2020-10-278-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1711754/000121390020033364/0001213900-20-033364-index.htm
2020-11-0510-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1711754/000121390020035280/0001213900-20-035280-index.htm
2020-11-068-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1711754/000121390020035449/0001213900-20-035449-index.htm
2019-02-11SC 13DGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1711754/000164033419000218/0001640334-19-000218-index.htm
2019-02-11SC 13DGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1711754/000164033419000219/0001640334-19-000219-index.htm
2019-02-11SC 13DGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1711754/000164033419000220/0001640334-19-000220-index.htm
2019-02-138-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1711754/000164033419000238/0001640334-19-000238-index.htm
2019-02-288-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1711754/000164033419000337/0001640334-19-000337-index.htm
2019-03-04SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1711754/000164033419000350/0001640334-19-000350-index.htm
2019-03-138-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1711754/000164033419000374/0001640334-19-000374-index.htm
2019-03-2910-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1711754/000164033419000466/0001640334-19-000466-index.htm
2019-04-048-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1711754/000164033419000543/0001640334-19-000543-index.htm
2019-04-128-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1711754/000164033419000577/0001640334-19-000577-index.htm
2019-04-198-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1711754/000164033419000661/0001640334-19-000661-index.htm
2019-04-298-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1711754/000164033419000708/0001640334-19-000708-index.htm
2019-05-068-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1711754/000164033419000755/0001640334-19-000755-index.htm
2019-05-064Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1711754/000164033419000758/0001640334-19-000758-index.htm
2019-05-074Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1711754/000164033419000761/0001640334-19-000761-index.htm
2019-05-094/AStatement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1711754/000164033419000793/0001640334-19-000793-index.htm
2019-05-10DNotice of Exempt Offering of Securitieshttps://www.sec.gov/Archives/edgar/data/1711754/000164033419000800/0001640334-19-000800-index.htm
2019-05-103Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1711754/000164033419000817/0001640334-19-000817-index.htm
2019-05-104Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1711754/000164033419000820/0001640334-19-000820-index.htm
2019-05-138-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1711754/000164033419000834/0001640334-19-000834-index.htm
2019-05-1510-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1711754/000164033419000853/0001640334-19-000853-index.htm
2019-05-168-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1711754/000164033419000899/0001640334-19-000899-index.htm
2019-05-178-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1711754/000164033419000911/0001640334-19-000911-index.htm
2019-05-204/AStatement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1711754/000164033419000940/0001640334-19-000940-index.htm
2019-05-204/AStatement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1711754/000164033419000942/0001640334-19-000942-index.htm
2019-05-248-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1711754/000164033419000971/0001640334-19-000971-index.htm
2019-05-248-K/ACurrent reporthttps://www.sec.gov/Archives/edgar/data/1711754/000164033419000974/0001640334-19-000974-index.htm
2019-05-298-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1711754/000164033419000996/0001640334-19-000996-index.htm
2019-06-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1711754/000164033419001033/0001640334-19-001033-index.htm
2019-06-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1711754/000164033419001035/0001640334-19-001035-index.htm
2019-06-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1711754/000164033419001039/0001640334-19-001039-index.htm
2019-06-048-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1711754/000164033419001049/0001640334-19-001049-index.htm
2019-06-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1711754/000164033419001052/0001640334-19-001052-index.htm
2019-06-068-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1711754/000164033419001070/0001640334-19-001070-index.htm
2019-06-10SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1711754/000164033419001099/0001640334-19-001099-index.htm
2019-06-178-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1711754/000164033419001161/0001640334-19-001161-index.htm
2019-06-208-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1711754/000164033419001172/0001640334-19-001172-index.htm
2019-06-21S-1General form for registration of securities under the Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1711754/000164033419001189/0001640334-19-001189-index.htm
2019-06-248-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1711754/000164033419001220/0001640334-19-001220-index.htm
2019-06-268-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1711754/000164033419001240/0001640334-19-001240-index.htm
2019-06-27CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1711754/000164033419001254/0001640334-19-001254-index.htm
2019-06-288-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1711754/000164033419001259/0001640334-19-001259-index.htm
2019-07-03424B3Prospectus [Rule 424(b)(3)]https://www.sec.gov/Archives/edgar/data/1711754/000164033419001285/0001640334-19-001285-index.htm
2019-07-038-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1711754/000164033419001293/0001640334-19-001293-index.htm
2019-07-098-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1711754/000164033419001309/0001640334-19-001309-index.htm
2019-07-18S-1General form for registration of securities under the Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1711754/000164033419001410/0001640334-19-001410-index.htm
2019-07-24CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1711754/000164033419001451/0001640334-19-001451-index.htm
2019-07-26424B3Prospectus [Rule 424(b)(3)]https://www.sec.gov/Archives/edgar/data/1711754/000164033419001474/0001640334-19-001474-index.htm
2019-07-29PRE 14AOther preliminary proxy statementshttps://www.sec.gov/Archives/edgar/data/1711754/000164033419001480/0001640334-19-001480-index.htm
2019-07-308-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1711754/000164033419001494/0001640334-19-001494-index.htm
2019-08-018-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1711754/000164033419001511/0001640334-19-001511-index.htm
2019-08-078-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1711754/000164033419001540/0001640334-19-001540-index.htm
2019-08-0910-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1711754/000164033419001563/0001640334-19-001563-index.htm
2019-08-098-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1711754/000164033419001566/0001640334-19-001566-index.htm
2019-08-09DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/1711754/000164033419001577/0001640334-19-001577-index.htm
2019-07-02EFFECTNotice of Effectivenesshttps://www.sec.gov/Archives/edgar/data/1711754/999999999519001521/9999999995-19-001521-index.htm
2019-07-26EFFECTNotice of Effectivenesshttps://www.sec.gov/Archives/edgar/data/1711754/999999999519001719/9999999995-19-001719-index.htm
2020-04-02EFFECTNotice of Effectivenesshttps://www.sec.gov/Archives/edgar/data/1711754/999999999520000673/9999999995-20-000673-index.htm
2020-04-20EFFECTNotice of Effectivenesshttps://www.sec.gov/Archives/edgar/data/1711754/999999999520000788/9999999995-20-000788-index.htm

INmune Bio, Inc (INMB) Insider Transactions:

Here you will find a list of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of INmune Bio, Inc (INMB). Company insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.
Insider Ownership: 4507%
Institutional Ownership: 1261%

Transaction Date Insider Name Insider Title Type Shares Number Shares Price Total Transaction Shares Held After Transaction Link
2019-05-08-06:00Linda F Powers10% Share HolderBuy61,667.009.00555,003.001,120,000.00https://www.sec.gov/Archives/edgar/data/1711754/000164033419000820/0001640334-19-000820-index.htm
2019-06-03-06:00Linda F Powers10% Share HolderBuy10,000.006.0060,000.001,130,000.00https://www.sec.gov/Archives/edgar/data/1711754/000164033419001052/0001640334-19-001052-index.htm
2019-05-06-06:00David J MossCFO, Treasurer & SecretaryBuy5,000.009.0045,000.001,210,417.00https://www.sec.gov/Archives/edgar/data/1711754/000164033419000761/0001640334-19-000761-index.htm
2019-06-03-06:00David J MossCFO, Treasurer & SecretaryBuy10,000.006.0060,000.001,220,417.00https://www.sec.gov/Archives/edgar/data/1711754/000164033419001035/0001640334-19-001035-index.htm
2019-08-20David J MossCFO, Treasurer & SecretaryBuy77.005.65435.051,220,494.00https://www.sec.gov/Archives/edgar/data/1711754/000121390019016455/0001213900-19-016455-index.htm
2019-08-20David J MossCFO, Treasurer & SecretaryBuy239.005.651,350.351,220,733.00https://www.sec.gov/Archives/edgar/data/1711754/000121390019016455/0001213900-19-016455-index.htm
2019-08-20David J MossCFO, Treasurer & SecretaryBuy2,000.005.6511,300.001,222,733.00https://www.sec.gov/Archives/edgar/data/1711754/000121390019016455/0001213900-19-016455-index.htm
2019-08-20David J MossCFO, Treasurer & SecretaryBuy72.005.65406.801,222,805.00https://www.sec.gov/Archives/edgar/data/1711754/000121390019016455/0001213900-19-016455-index.htm
2019-08-20David J MossCFO, Treasurer & SecretaryBuy236.005.651,333.401,223,041.00https://www.sec.gov/Archives/edgar/data/1711754/000121390019016455/0001213900-19-016455-index.htm
2019-08-20David J MossCFO, Treasurer & SecretaryBuy376.005.652,124.401,223,417.00https://www.sec.gov/Archives/edgar/data/1711754/000121390019016455/0001213900-19-016455-index.htm
2019-09-11Mark William LowdellChief Scientific OfficerBuy2,918.006.2318,178.561,506,251.00https://www.sec.gov/Archives/edgar/data/1711754/000121390019017904/0001213900-19-017904-index.htm
2019-05-02-06:00Raymond Joseph TesiChairmanBuy11,100.009.90109,890.001,526,933.00https://www.sec.gov/Archives/edgar/data/1711754/000164033419000758/0001640334-19-000758-index.htm
2019-06-03-06:00Raymond Joseph TesiPresident & CEOBuy10,000.006.0060,000.001,536,933.00https://www.sec.gov/Archives/edgar/data/1711754/000164033419001033/0001640334-19-001033-index.htm
2019-08-09Raymond Joseph TesiPresident & CEOBuy100.007.20720.001,537,033.00https://www.sec.gov/Archives/edgar/data/1711754/000121390019015380/0001213900-19-015380-index.htm
2019-08-09Raymond Joseph TesiPresident & CEOBuy900.007.146,428.791,537,933.00https://www.sec.gov/Archives/edgar/data/1711754/000121390019015380/0001213900-19-015380-index.htm
2019-08-09Raymond Joseph TesiPresident & CEOBuy1,000.006.916,909.501,538,933.00https://www.sec.gov/Archives/edgar/data/1711754/000121390019015380/0001213900-19-015380-index.htm
2019-08-20Raymond Joseph TesiPresident & CEOBuy100.005.96596.001,539,033.00https://www.sec.gov/Archives/edgar/data/1711754/000121390019016453/0001213900-19-016453-index.htm
2019-08-20Raymond Joseph TesiPresident & CEOBuy100.005.96596.001,539,133.00https://www.sec.gov/Archives/edgar/data/1711754/000121390019016453/0001213900-19-016453-index.htm
2019-08-20Raymond Joseph TesiPresident & CEOBuy100.005.96596.001,539,233.00https://www.sec.gov/Archives/edgar/data/1711754/000121390019016453/0001213900-19-016453-index.htm
2019-08-20Raymond Joseph TesiPresident & CEOBuy100.005.96596.001,539,333.00https://www.sec.gov/Archives/edgar/data/1711754/000121390019016453/0001213900-19-016453-index.htm
2019-08-20Raymond Joseph TesiPresident & CEOBuy100.005.96596.001,539,433.00https://www.sec.gov/Archives/edgar/data/1711754/000121390019016453/0001213900-19-016453-index.htm
2019-08-20Raymond Joseph TesiPresident & CEOBuy100.005.96596.001,539,533.00https://www.sec.gov/Archives/edgar/data/1711754/000121390019016453/0001213900-19-016453-index.htm
2019-08-20Raymond Joseph TesiPresident & CEOBuy100.005.96596.001,539,633.00https://www.sec.gov/Archives/edgar/data/1711754/000121390019016453/0001213900-19-016453-index.htm
2019-08-20Raymond Joseph TesiPresident & CEOBuy100.005.96596.001,539,733.00https://www.sec.gov/Archives/edgar/data/1711754/000121390019016453/0001213900-19-016453-index.htm
2019-08-20Raymond Joseph TesiPresident & CEOBuy100.005.96596.001,539,833.00https://www.sec.gov/Archives/edgar/data/1711754/000121390019016453/0001213900-19-016453-index.htm
2019-08-20Raymond Joseph TesiPresident & CEOBuy100.005.92592.391,539,933.00https://www.sec.gov/Archives/edgar/data/1711754/000121390019016453/0001213900-19-016453-index.htm
2019-08-20Raymond Joseph TesiPresident & CEOBuy1,000.006.036,030.801,540,933.00https://www.sec.gov/Archives/edgar/data/1711754/000121390019016453/0001213900-19-016453-index.htm
2020-01-27Linda F Powers10% Share HolderSell220,000.004.601,012,000.00210,000.00https://www.sec.gov/Archives/edgar/data/1711754/000110465920008253/0001104659-20-008253-index.htm
2019-06-03-06:00Scott JudaDirectorBuy10,000.006.0060,000.0022,500.00https://www.sec.gov/Archives/edgar/data/1711754/000164033419001039/0001640334-19-001039-index.htm
2019-08-20Scott JudaDirectorBuy2,500.006.0015,000.0025,000.00https://www.sec.gov/Archives/edgar/data/1711754/000121390019016514/0001213900-19-016514-index.htm
2019-08-21Scott JudaDirectorBuy2,500.006.0015,000.0027,500.00https://www.sec.gov/Archives/edgar/data/1711754/000121390019016514/0001213900-19-016514-index.htm